At this point it has to be mentioned, that most of our knowledge about the biological actions of GLPs on lipid metabolism are derived from studies with long term GLP administration or animal gene knockout models, especially in the postprandial setting, as the scope of incretin research, up to date, has been focusing mainly on disease from metabolic syndrome. The gene discussed is GCG; the disease is metabolic syndrome.